July 23, 2019
Jamie Blundell, President & COO is pleased to provide the following update on Scientus Pharma, one of CGOC’s private holdings:
HydRx Farms Ltd. (operating as Scientus Pharma Inc. “Scientus Pharma”), one of CGOC’s private portfolio holdings, provided shareholders with an update regarding the product launch for their decarboxylated oils and capsules, branded as “Medisenol”, and concludes a $5.5 million financing.
Medisenol Product Launch
The Medisenol brand was inspired by extensive research with patients and health care practitioners (HCPs). Medisenol strives to help patients navigate through the noise, confusion and stigma around medical cannabis. The website features content that was designed specifically for patients suffering from chronic pain. It also provides potential patients with the opportunity to connect to a health care professional for a virtual medical cannabis consult through the telehealth portal of partner company, HelloMD.
Please visit the e-commerce website at www.medisenol.com to send your Medical Document, register as a patient and shop for Medisenol products. Persons who do not yet have a prescription and need one are encouraged to visit the Medisenol website for a Virtual Medical Consult.
Scientus Pharma has concluded a $5.5 million financing executed through a non-brokered private placement.
About Scientus Pharma Inc.
Scientus Pharma Inc. conducts scientific research on cannabinoids with a focus on developing and commercializing pharmaceutical-grade cannabinoid derivative products. Scientus Pharma is a vertically-integrated biopharmaceutical Licensed Producer under the Cannabis Act and its Regulations and also a Licensed Dealer under the Narcotics Control Act and its Regulations.
Scientus Pharma is one of a limited number of Licensed Producers in Canada authorized to conduct R&D and fully handle cannabinoid products with the ability to wholesale, buy, process and sell cannabinoid derivatives, from and to other Licensed Producers, as well as international markets.
For more information, please visit www.scientuspharma.com.
|E-UPDATES – Sign up here to be included in our email blasts and receive timely updates
For further information please contact Cannabis Growth Opportunity Corporation: